Serum Bicarbonate in Acute Heart Failure: Relationship to Treatment Strategies and Clinical Outcomes

Journal of Cardiac Failure
Lauren B CooperG Michael Felker

Abstract

Though commonly noted in clinical practice, it is unknown if decongestion in acute heart failure (AHF) results in increased serum bicarbonate. For 678 AHF patients in the DOSE-AHF, CARRESS-HF, and ROSE-AHF trials, we assessed change in bicarbonate (baseline to 72-96 hours) according to decongestion strategy, and the relationship between bicarbonate change and protocol-defined decongestion. Median baseline bicarbonate was 28 mEq/L. Patients with baseline bicarbonate ≥28 mEq/L had lower ejection fraction, worse renal function and higher N-terminal pro-B-type natriuretic peptide than those with baseline bicarbonate <28 mEq/L. There were no differences in bicarbonate change between treatment groups in DOSE-AHF or ROSE-AHF (all P > .1). In CARRESS-HF, bicarbonate increased with pharmacologic care but decreased with ultrafiltration (median +3.3 vs -0.9 mEq/L, respectively; P < .001). Bicarbonate change was not associated with successful decongestion (P > .2 for all trials). In AHF, serum bicarbonate is most commonly elevated in patients with more severe heart failure. Despite being used in clinical practice as an indicator for decongestion, change in serum bicarbonate was not associated with significant decongestion.

References

Nov 23, 2006·The American Journal of Medicine·Mihai GheorghiadeJohn Burnett
Sep 15, 2009·Circulation. Heart Failure·G Michael FelkerUNKNOWN Heart Failure Clinical Research Network Investigators
Mar 4, 2011·The New England Journal of Medicine·G Michael FelkerUNKNOWN NHLBI Heart Failure Clinical Research Network
Nov 22, 2011·Seminars in Nephrology·Biff F Palmer
Nov 8, 2012·The New England Journal of Medicine·Bradley A BartUNKNOWN Heart Failure Clinical Research Network
Mar 14, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Aldo J Peixoto, Robert J Alpern
Nov 20, 2013·JAMA : the Journal of the American Medical Association·Horng H ChenUNKNOWN NHLBI Heart Failure Clinical Research Network
Dec 19, 2014·Circulation·Dariush MozaffarianUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee

❮ Previous
Next ❯

Citations

Jun 10, 2016·Current Heart Failure Reports·Justin L Grodin
Jan 11, 2017·Circulation. Heart Failure·Koen W StrengPeter van der Meer
Nov 16, 2017·The New England Journal of Medicine·David H Ellison, G Michael Felker
Sep 15, 2019·Heart Failure Reviews·Zachary L Cox, Jeffrey M Testani
Aug 11, 2020·Cardiology and Therapy·Joseph J CuthbertAndrew L Clark
Mar 14, 2020·Journal of the American College of Cardiology·G Michael FelkerJeffrey M Testani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Argentine Hemorrhagic Fever

Argentine hemorrhagic fever (AHF) is an endemo-epidemic disease caused by junín virus (JUNV), a member of the arenaviridae family. Discover the latest research on AHF here.